Catalyst Wire Dossier Catalyst Wire Dossier

Cladribine tablets

cladribine · Merck KGaA
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Cladribine tablets, covering 2022-01-13 to 2026-07-28. Get the full timeline:

Most recent: Clinical Trial Results: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]

See pricing